Ginkgo Bioworks Hldgs Inc (DNA)

$7.97 -0.53 (-6.24%)
Market Cap 555.25M
Revenue (ttm) 170.16M
Net Income (ttm) -312.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -183.80%
Debt to Equity Ratio 0.00
Volume 1,653,600
Avg Vol 1,173,662
Day's Range N/A - N/A
Shares Out 65.32M
Stochastic %K 31%
Beta 1.78
Analysts Hold
Price Target $8.67

Company Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the re...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 422 5362
Address:
27 Drydock Avenue, 8th Floor, Boston, United States
the_end
the_end Aug. 24 at 6:23 PM
$DNA now the fun starts. us to put economic sanctions on iran. us to also put pressure on countries trading with iran. which now includes india and china. if india and china retaliate like canada, pharma API and KSM might be a problem for big pharma. india supplies generics, so that may or may not double down on supply depending on india us relations which I don't see going great for now. trump will have to check internally if it can deal with such retaliations, remember he has put 100% tariffs on imports of generics from 2028. if any of that escalates, the pressure will be on home grown pharma companies. trump may use this setup to introduce biosecure, BINSA, coins etc acts. all the while ginkgo might not be prepared, and the stock price may hit 5 not just due to unprepared ness but trade wars in markets too. so the under 5 target is still on.
1 · Reply
the_end
the_end Aug. 24 at 6:01 PM
$DNA when you sell dreams, some labs actually convert dreams to reality. Singapore launches world-first data center powered by human brain cells The 20-unit system reportedly uses lab-grown brain cells integrated with silicon chips to generate computing power. The facility comprises 20 CL1 biological computers, each containing at least 200,000 lab-grown human neurons on an electrode-fitted silicon chip. Derived from blood cells reprogrammed into stem cells, the neurons exchange electrical signals with conventional hardware, turning their activity into computing power. too late, the world is racing ahead much faster.
1 · Reply
AdrianRoth
AdrianRoth Aug. 24 at 5:45 PM
$DNA what a disaster…
0 · Reply
jaydilks
jaydilks Aug. 24 at 9:54 AM
$DNA Don’t overthink it with DNA. It follows Bitcoin for a year and tends to go down as much but up much more. This week it catches UP. DNA is the line that surges HIGHER. It’s a Risk ON trade. $IBIT . Own both. In IBIT doubles from here, DNA triples from here. They have absolutely nothing to do with each other beyond the risk. It’s highly likely IBIT has a 100% run from its lows. DNA should follow. Ginkgo Biowork’s last earnings call was a throwing in the kitchen sink for negative news. They have an outside shot of being profitable as we enter 2027 simply from earned milestones. The chart below tells no lies. VERY symmetrical patterns.
1 · Reply
the_end
the_end Aug. 24 at 4:15 AM
$DNA hmmm Ginkgo Bioworks is actively hiring a Director, Government Partnership Development to expand its strategic relationships and sales pipeline with U.S. federal agencies like HHS and the Department of Defense. after shyam sankar left, who taught them how to orchestrate govt deals. i guess they now need to lobby trump loyalists for this role. they have no money to put a PR in PR newswire, so they use they social media handles to save money, how will they pay these executive level roles ...
1 · Reply
the_end
the_end Aug. 24 at 2:25 AM
$DNA looks like i got a lot of hate... but they don't mute or block me. because that is human nature, fear always attracts more. well I'll give you a hint. have a look at all the interviews the company gives on podcasts etc, i am sure you are in awe of the future we have wrt programming biology, and before you ride in those clouds, why such a thing cannot be converted in some revenue should be your immediate question. have a look at the interviews for last 6 years, get charmed by the science of the future, but then pay attention to , are we making any money yet. that should give you an idea why I say where the stock price should be. maybe they should author some courses on udemy using labs so that people can learn how to use labs and atleast pay some money for subscription while learning ..
2 · Reply
the_end
the_end Aug. 23 at 2:59 PM
$DNA i guess I should let you all know. if you think my comments actually impact the stock price or destroy your morale holding this penny stock, well mute me or block me or report me or rather buy more because i am wrong at everything I say. make money, i cannot stop you. but I am certain this is bigger than just fraud . you cannot simply say everything you tried just failed when at one point you estimated 1 billion dollars in revenue in a financial year. that is like a noob given a billion dollars and they get crazy that they touched unicorn status so early in life without really making a useful product. i will keep splitting facts , which not many will like it, till it does under 5. the company needs to kiss that wall of shame so that it rememebers , people don't forget your lies.
1 · Reply
the_end
the_end Aug. 23 at 5:43 AM
$DNA last time after the BWC, there was mpox threa in india. india said it is preparing for it by ordering test kits etc. this time after the BWC event last week, india now officially gives alert for wearing masks in crowded places wrt h1n1. those are protests sites by students. strange thing that diseases erupt out of places of demonstration... makes me believe it's not mother nature but a masochist human who cares less about life. his fake meat company is getting destroyed and it went into reverse split just like ginkgo. so this is why this is bullish even when it was bearish last week. sick ....
1 · Reply
the_end
the_end Aug. 22 at 8:54 AM
$DNA trade talks with canada fail. tariffs back. hormuz drama back. anthropic says ai backlash a possible risk. openai is jittery , does not want to ipo now.cit any hope of ginkgo and openai, delayed. ray dalio says govt buying its own treasury is a sign of crisis. i was right. this is just a take your money and run rallies. penny stocks is how institutions contain inflation from retail. if retail make money, inflation risk increases.
0 · Reply
the_end
the_end Aug. 22 at 5:06 AM
$DNA will serber, who was the head of automation, left ginkgo a couple of months back. the same person who indirectly made a mention of ginkgo revenue to be 200mn at the deploying and scaling autonomous labs with openai and pnnl. when nita madhav leftz I was sure ginkgo biosecurity will make a suprise call. now ginkgo bioworks will make one more surprise. i am confident 1:40 reverse split company cannot survive, the history says this loud and clear. maybe there is some news, but when people are leaving the ship, that is not a long term good news. glta
0 · Reply
Latest News on DNA
Ginkgo Bioworks downgraded to Hold from Buy at TD Cowen

2026-08-07T08:35:20.000Z - 17 days ago

Ginkgo Bioworks downgraded to Hold from Buy at TD Cowen

Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 18 days ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2026

Ginkgo Bioworks Holdings Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 18 days ago

Ginkgo Bioworks Holdings Earnings release: Q2 2026

Ginkgo Bioworks Holdings Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 18 days ago

Ginkgo Bioworks Holdings Slides: Q2 2026

Ginkgo Bioworks Holdings Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 18 days ago

Ginkgo Bioworks Holdings Quarterly report: Q2 2026

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

May 26, 2026, 12:33 PM EDT - 3 months ago

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M)

2026-05-07T20:55:19.000Z - 3 months ago

Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M)

Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2026

Ginkgo Bioworks Holdings Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Ginkgo Bioworks Holdings Earnings release: Q1 2026

Ginkgo Bioworks Holdings Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Ginkgo Bioworks Holdings Quarterly report: Q1 2026

Ginkgo Bioworks Holdings Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Ginkgo Bioworks Holdings Slides: Q1 2026

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

May 7, 2026, 4:05 PM EDT - 3 months ago

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Apr 30, 2026, 8:01 AM EDT - 4 months ago

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Ginkgo Bioworks Holdings Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Ginkgo Bioworks Holdings Proxy statement: Proxy filing

Ginkgo Bioworks Holdings Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Ginkgo Bioworks Holdings Proxy statement: Proxy filing

Ginkgo Bioworks price target lowered to $5 from $9 at BTIG

2026-03-12T11:31:37.000Z - 5 months ago

Ginkgo Bioworks price target lowered to $5 from $9 at BTIG

Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure

Mar 2, 2026, 8:00 AM EST - 6 months ago

Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure

Ginkgo Bioworks expects total cash burn of ($150M)-($125M) in 2026

2026-02-26T22:05:39.000Z - 6 months ago

Ginkgo Bioworks expects total cash burn of ($150M)-($125M) in 2026

Ginkgo Bioworks Holdings Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q4 2025

Ginkgo Bioworks Holdings Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Ginkgo Bioworks Holdings Annual report: Q4 2025

Ginkgo Bioworks Holdings Earnings release: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Ginkgo Bioworks Holdings Earnings release: Q4 2025

Ginkgo Bioworks Holdings Slides: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Ginkgo Bioworks Holdings Slides: Q4 2025

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

Feb 26, 2026, 4:26 PM EST - 6 months ago

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation

Feb 19, 2026, 8:00 AM EST - 6 months ago

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation

Ginkgo Bioworks, Invaio Sciences enter collaboration

2026-02-18T13:06:31.000Z - 6 months ago

Ginkgo Bioworks, Invaio Sciences enter collaboration

Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products

Feb 18, 2026, 8:00 AM EST - 6 months ago

Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products

Ginkgo Bioworks jumps after OpenAI comment on working together

2026-02-05T19:15:16.000Z - 7 months ago

Ginkgo Bioworks jumps after OpenAI comment on working together

Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark

Feb 5, 2026, 2:00 PM EST - 7 months ago

Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark

Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 8:00 AM EST - 7 months ago

Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks price target lowered to $12 from $14 at TD Cowen

2026-01-08T14:45:31.000Z - 8 months ago

Ginkgo Bioworks price target lowered to $12 from $14 at TD Cowen

Ginkgo Bioworks price target lowered to $12 from $142 at TD Cowen

2026-01-08T14:42:16.000Z - 8 months ago

Ginkgo Bioworks price target lowered to $12 from $142 at TD Cowen

Ginkgo Bioworks partnres with CMU to develop cancer screening approach

2025-12-22T18:25:26.000Z - 8 months ago

Ginkgo Bioworks partnres with CMU to develop cancer screening approach

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

Dec 22, 2025, 1:21 PM EST - 8 months ago

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

Ginkgo Bioworks, Agricen enter collaboration

2025-12-17T13:05:46.000Z - 8 months ago

Ginkgo Bioworks, Agricen enter collaboration

Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment

Dec 17, 2025, 8:00 AM EST - 8 months ago

Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment

ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies

Dec 11, 2025, 8:46 AM EST - 9 months ago

ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies

Ginkgo Bioworks partners with Deep Origin to develop new drug safety tools

2025-12-09T13:10:54.000Z - 9 months ago

Ginkgo Bioworks partners with Deep Origin to develop new drug safety tools

Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

Dec 9, 2025, 8:00 AM EST - 9 months ago

Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

Ginkgo Bioworks awarded four-year, up to $47M contract from EMSL

2025-12-05T13:40:16.000Z - 9 months ago

Ginkgo Bioworks awarded four-year, up to $47M contract from EMSL

Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC

Dec 5, 2025, 8:33 AM EST - 9 months ago

Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC

STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

Dec 3, 2025, 8:00 AM EST - 9 months ago

STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

Nov 18, 2025, 8:00 AM EST - 9 months ago

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

Ginkgo Bioworks still sees FY25 revenue $167M-$187M, consensus $177.07M

2025-11-06T21:38:08.000Z - 10 months ago

Ginkgo Bioworks still sees FY25 revenue $167M-$187M, consensus $177.07M

Ginkgo Bioworks Holdings Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q3 2025

Ginkgo Bioworks Holdings Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Ginkgo Bioworks Holdings Quarterly report: Q3 2025

Ginkgo Bioworks Holdings Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Ginkgo Bioworks Holdings Earnings release: Q3 2025

Ginkgo Bioworks Holdings Slides: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Ginkgo Bioworks Holdings Slides: Q3 2025

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium

Nov 3, 2025, 8:00 AM EST - 10 months ago

Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium

DCI

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

Oct 31, 2025, 8:00 AM EDT - 10 months ago

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation

Oct 30, 2025, 4:05 PM EDT - 10 months ago

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

Oct 23, 2025, 8:00 AM EDT - 10 months ago

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions

Aug 29, 2025, 4:05 PM EDT - 1 year ago

Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry

Aug 20, 2025, 8:01 AM EDT - 1 year ago

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth

Aug 12, 2025, 8:01 AM EDT - 1 year ago

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth

Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2025

Ginkgo Bioworks Holdings Quarterly report: Q2 2025

Aug 7, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Quarterly report: Q2 2025

Ginkgo Bioworks Holdings Earnings release: Q2 2025

Aug 7, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Earnings release: Q2 2025

Ginkgo Bioworks Holdings Slides: Q2 2025

Aug 7, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Slides: Q2 2025

Ginkgo Bioworks Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 5:01 PM EDT - 1 year ago

Ginkgo Bioworks Reports Second Quarter 2025 Financial Results

Ginkgo Bioworks Holdings Registration statement: Registration Filing

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Ginkgo Bioworks Holdings Registration statement: Registration Filing

Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

Jul 31, 2025, 8:01 AM EDT - 1 year ago

Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy

Jul 30, 2025, 9:01 AM EDT - 1 year ago

Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors

Jul 17, 2025, 9:01 AM EDT - 1 year ago

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

May 21, 2025, 4:05 PM EDT - 1 year ago

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

May 8, 2025, 8:00 AM EDT - 1 year ago

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

TWST

Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2025

May 6, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2025

Ginkgo Bioworks Holdings Quarterly report: Q1 2025

May 6, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Quarterly report: Q1 2025

Ginkgo Bioworks Holdings Earnings release: Q1 2025

May 6, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Earnings release: Q1 2025

Ginkgo Bioworks Holdings Slides: Q1 2025

May 6, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Slides: Q1 2025

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

May 6, 2025, 5:00 PM EDT - 1 year ago

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Apr 30, 2025, 9:00 AM EDT - 1 year ago

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Apr 29, 2025, 4:00 PM EDT - 1 year ago

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Ginkgo Bioworks Holdings Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Ginkgo Bioworks Holdings Proxy statement: Proxy Filing

Ginkgo Bioworks Holdings Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Ginkgo Bioworks Holdings Proxy statement: Proxy Filing

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Apr 22, 2025, 9:00 AM EDT - 1 year ago

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

Apr 10, 2025, 9:00 AM EDT - 1 year ago

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

DCI

Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways

Apr 3, 2025, 9:01 AM EDT - 1 year ago

Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways

Ginkgo Bioworks Holdings Earnings Call Transcript: Q4 2024

Feb 25, 2025, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q4 2024

Ginkgo Bioworks Holdings Annual report: Q4 2024

Feb 25, 2025, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Annual report: Q4 2024

Ginkgo Bioworks Holdings Earnings release: Q4 2024

Feb 25, 2025, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Earnings release: Q4 2024

Ginkgo Bioworks Holdings Slides: Q4 2024

Feb 25, 2025, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Slides: Q4 2024

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 5:00 PM EST - 1 year ago

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Feb 21, 2025, 9:00 AM EST - 1 year ago

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Feb 20, 2025, 8:01 AM EST - 1 year ago

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Feb 18, 2025, 8:00 AM EST - 1 year ago

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Feb 6, 2025, 8:01 AM EST - 1 year ago

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

Jan 23, 2025, 8:01 AM EST - 1 year ago

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development

Jan 21, 2025, 7:00 AM EST - 1 year ago

SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development

Ginkgo Bioworks Holdings Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 16, 2025, 1:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Ginkgo Bioworks Holdings Slides: FY 2025

Jan 16, 2025, 1:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Slides: FY 2025

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Jan 13, 2025, 8:01 AM EST - 1 year ago

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics

Jan 9, 2025, 11:38 AM EST - 1 year ago

Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 8:00 AM EST - 1 year ago

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Dec 17, 2024, 8:11 AM EST - 1 year ago

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Ginkgo Bioworks Holdings Earnings Call Transcript: Q3 2024

Nov 12, 2024, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q3 2024

Ginkgo Bioworks Holdings Quarterly report: Q3 2024

Nov 12, 2024, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Quarterly report: Q3 2024

Ginkgo Bioworks Holdings Earnings release: Q3 2024

Nov 12, 2024, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Earnings release: Q3 2024

Ginkgo Bioworks Holdings Slides: Q3 2024

Nov 12, 2024, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Slides: Q3 2024

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 5:01 PM EST - 1 year ago

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

Nov 12, 2024, 8:01 AM EST - 1 year ago

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

the_end
the_end Aug. 24 at 6:23 PM
$DNA now the fun starts. us to put economic sanctions on iran. us to also put pressure on countries trading with iran. which now includes india and china. if india and china retaliate like canada, pharma API and KSM might be a problem for big pharma. india supplies generics, so that may or may not double down on supply depending on india us relations which I don't see going great for now. trump will have to check internally if it can deal with such retaliations, remember he has put 100% tariffs on imports of generics from 2028. if any of that escalates, the pressure will be on home grown pharma companies. trump may use this setup to introduce biosecure, BINSA, coins etc acts. all the while ginkgo might not be prepared, and the stock price may hit 5 not just due to unprepared ness but trade wars in markets too. so the under 5 target is still on.
1 · Reply
the_end
the_end Aug. 24 at 6:01 PM
$DNA when you sell dreams, some labs actually convert dreams to reality. Singapore launches world-first data center powered by human brain cells The 20-unit system reportedly uses lab-grown brain cells integrated with silicon chips to generate computing power. The facility comprises 20 CL1 biological computers, each containing at least 200,000 lab-grown human neurons on an electrode-fitted silicon chip. Derived from blood cells reprogrammed into stem cells, the neurons exchange electrical signals with conventional hardware, turning their activity into computing power. too late, the world is racing ahead much faster.
1 · Reply
AdrianRoth
AdrianRoth Aug. 24 at 5:45 PM
$DNA what a disaster…
0 · Reply
jaydilks
jaydilks Aug. 24 at 9:54 AM
$DNA Don’t overthink it with DNA. It follows Bitcoin for a year and tends to go down as much but up much more. This week it catches UP. DNA is the line that surges HIGHER. It’s a Risk ON trade. $IBIT . Own both. In IBIT doubles from here, DNA triples from here. They have absolutely nothing to do with each other beyond the risk. It’s highly likely IBIT has a 100% run from its lows. DNA should follow. Ginkgo Biowork’s last earnings call was a throwing in the kitchen sink for negative news. They have an outside shot of being profitable as we enter 2027 simply from earned milestones. The chart below tells no lies. VERY symmetrical patterns.
1 · Reply
the_end
the_end Aug. 24 at 4:15 AM
$DNA hmmm Ginkgo Bioworks is actively hiring a Director, Government Partnership Development to expand its strategic relationships and sales pipeline with U.S. federal agencies like HHS and the Department of Defense. after shyam sankar left, who taught them how to orchestrate govt deals. i guess they now need to lobby trump loyalists for this role. they have no money to put a PR in PR newswire, so they use they social media handles to save money, how will they pay these executive level roles ...
1 · Reply
the_end
the_end Aug. 24 at 2:25 AM
$DNA looks like i got a lot of hate... but they don't mute or block me. because that is human nature, fear always attracts more. well I'll give you a hint. have a look at all the interviews the company gives on podcasts etc, i am sure you are in awe of the future we have wrt programming biology, and before you ride in those clouds, why such a thing cannot be converted in some revenue should be your immediate question. have a look at the interviews for last 6 years, get charmed by the science of the future, but then pay attention to , are we making any money yet. that should give you an idea why I say where the stock price should be. maybe they should author some courses on udemy using labs so that people can learn how to use labs and atleast pay some money for subscription while learning ..
2 · Reply
the_end
the_end Aug. 23 at 2:59 PM
$DNA i guess I should let you all know. if you think my comments actually impact the stock price or destroy your morale holding this penny stock, well mute me or block me or report me or rather buy more because i am wrong at everything I say. make money, i cannot stop you. but I am certain this is bigger than just fraud . you cannot simply say everything you tried just failed when at one point you estimated 1 billion dollars in revenue in a financial year. that is like a noob given a billion dollars and they get crazy that they touched unicorn status so early in life without really making a useful product. i will keep splitting facts , which not many will like it, till it does under 5. the company needs to kiss that wall of shame so that it rememebers , people don't forget your lies.
1 · Reply
the_end
the_end Aug. 23 at 5:43 AM
$DNA last time after the BWC, there was mpox threa in india. india said it is preparing for it by ordering test kits etc. this time after the BWC event last week, india now officially gives alert for wearing masks in crowded places wrt h1n1. those are protests sites by students. strange thing that diseases erupt out of places of demonstration... makes me believe it's not mother nature but a masochist human who cares less about life. his fake meat company is getting destroyed and it went into reverse split just like ginkgo. so this is why this is bullish even when it was bearish last week. sick ....
1 · Reply
the_end
the_end Aug. 22 at 8:54 AM
$DNA trade talks with canada fail. tariffs back. hormuz drama back. anthropic says ai backlash a possible risk. openai is jittery , does not want to ipo now.cit any hope of ginkgo and openai, delayed. ray dalio says govt buying its own treasury is a sign of crisis. i was right. this is just a take your money and run rallies. penny stocks is how institutions contain inflation from retail. if retail make money, inflation risk increases.
0 · Reply
the_end
the_end Aug. 22 at 5:06 AM
$DNA will serber, who was the head of automation, left ginkgo a couple of months back. the same person who indirectly made a mention of ginkgo revenue to be 200mn at the deploying and scaling autonomous labs with openai and pnnl. when nita madhav leftz I was sure ginkgo biosecurity will make a suprise call. now ginkgo bioworks will make one more surprise. i am confident 1:40 reverse split company cannot survive, the history says this loud and clear. maybe there is some news, but when people are leaving the ship, that is not a long term good news. glta
0 · Reply
madnessofcrowds
madnessofcrowds Aug. 21 at 8:05 PM
$DNA still see a 7 handle
1 · Reply
the_end
the_end Aug. 21 at 5:09 PM
$DNA lol he posted this before the us hit 40 trillion dollar debt. so ...
0 · Reply
the_end
the_end Aug. 21 at 5:01 PM
$DNA how the institutions fool retail. last week sentiment was 18, absolutely bearish. going into this weekend it is 86. what did ginkgo do, nothing. did it get any revenue, none. this is the same as pump before run the until the earnings and then a rug pull. 3 qtrs, same old play. all those hedge funds are deployed on social media to trap new investors by fake runs. i saw on yahoo and now on stocktwits. this is a 1:40 reverse split stock, for 2 years now. this will fail ... no company has survived when they got scared and split.
0 · Reply
the_end
the_end Aug. 21 at 3:50 PM
$DNA when I heard pfizer ceo say, post 2028 they return to stronger growth. most gene therapy will go into commercialization of their therapy in late 2027 or 2028. currently the rallies are just pump and dump and grab capital. maybe the pump if for anthropic ipo like there was a pump for spacex. otherwise inflation will knock all penny stocks which have no revenue.
0 · Reply
the_end
the_end Aug. 21 at 3:42 PM
$DNA back under 7 before EOD. these rallies have nothing to do with ginkgo, players are just playing to trap. we are in a bear market , crypto and gold have started rallying back. the 40 trillion dollar debt will now generate a lot of pain. everyone is trying to squeeze a rally to get out with capital and create new bagholders ... be careful
0 · Reply
King_aj3
King_aj3 Aug. 21 at 1:39 PM
$SPY $AAPL $DNA Averaged Down On These. My New Average Is $1.78. This Is Extremely Risky.
0 · Reply
madnessofcrowds
madnessofcrowds Aug. 21 at 11:19 AM
$DNA some of our fair weather bulls are back. never good.
0 · Reply
TRILLIONCAP
TRILLIONCAP Aug. 20 at 8:34 PM
$DNA an very undervalued firm.
0 · Reply
the_end
the_end Aug. 20 at 7:30 PM
$DNA trump has announced economic warfare in public against its adversaries. so when a company shouts the name of its adversaries on a daily basis, why would you think that stock will get a push. stocks and politics , if they mix can get extremely risky.
0 · Reply
the_end
the_end Aug. 20 at 7:27 PM
$DNA make a note of its holding status. it went reverse split 1:40 , i have shared the stats of growth stocks with such large reverse splits. on the top of that. it holds shares from the past partnership. most of the companies shut down, so they hold negligible value. rather heavy loss. and others being penny stocks are suffering from inflation. so negative sentiment doubles down on ginkgo more than others in the segment because it is now a holdings company, of penny stocks or startups. be careful and be practical.
0 · Reply
MoneyMacG
MoneyMacG Aug. 20 at 7:26 PM
$BKSY $AMPG $ICHR $FRTT $DNA nn
0 · Reply
the_end
the_end Aug. 20 at 7:18 PM
$DNA there will be no mega returns. in fact it will struggle to stay afloat above its reverse split value of 9.76. today is the aniversary and it gets the same treatment as aug 20 2024. the ceo cfo both have accepted there will be no revenue for a very long time in the earnings call. even the new lab revenue will take much longer. till then cash burn projection is 150mn. cash in hand is 300mn. ginkgo is riding on someone else's news. this makes it a candidate of pump and dump. do not fall into the trap that peers are doing great so ginkgo automatically will do great. all analysts have gone with sell and reduce ratings. be careful. i mean enjoy science, it does good work, but not stock price
0 · Reply